Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclooxygenase-2 induction in congestive heart failure: friend or foe?

× No keyword cloud information.

8 in total

1. Cyclooxygenase products and atherosclerosis.

Authors: Macrae F Linton; Sergio Fazio
Journal: Drug Discov Today Ther Strateg Date: 2008

2. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.

Authors: Ying Sun; Oscar A Carretero; Jiang Xu; Nour-Eddine Rhaleb; Fangfei Wang; Chunxia Lin; James J Yang; Patrick J Pagano; Xiao-Ping Yang
Journal: Hypertension Date: 2005-11-14 Impact factor: 10.190

3. Regulation of the expression of cyclooxygenases and production of prostaglandin I₂ and E₂ in human coronary artery endothelial cells by curcumin.

Authors: X Tan; E M Poulose; V V Raveendran; B-T Zhu; D J Stechschulte; K N Dileepan
Journal: J Physiol Pharmacol Date: 2011-02 Impact factor: 3.011

4. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.

Authors: K Shinmura; X L Tang; Y Wang; Y T Xuan; S Q Liu; H Takano; A Bhatnagar; R Bolli
Journal: Proc Natl Acad Sci U S A Date: 2000-08-29 Impact factor: 11.205

Review 5. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors: Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal: Cardiovasc Res Date: 2002-08-15 Impact factor: 10.787

6. Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.

Authors: Patricia McGettigan; Pearline Han; Lisa Jones; Diana Whitaker; David Henry
Journal: Br J Clin Pharmacol Date: 2008-04-01 Impact factor: 4.335

7. Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.

Authors: Carmela Nacci; Mariela Tarquinio; Leonarda De Benedictis; Annamaria Mauro; Addolorata Zigrino; Maria Rosaria Carratù; Michael J Quon; Monica Montagnani
Journal: Endocrinology Date: 2008-10-09 Impact factor: 4.736

8. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.

Authors: Linlin Zhang; Mokan Deng; Aihua Lu; Yanting Chen; Yang Chen; Chunying Wu; Zhi Tan; Krishna M Boini; Tianxin Yang; Qing Zhu; Lei Wang
Journal: J Cell Mol Med Date: 2019-09-29 Impact factor: 5.310

8 in total